HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Donald B Kohn Selected Research

X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)

1/2021Gene Therapies for Primary Immune Deficiencies.
12/2014Eliminating SCID row: new approaches to SCID.
10/2014A modified γ-retrovirus vector for X-linked severe combined immunodeficiency.
8/2011A tale of two SCIDs.
5/2010Update on gene therapy for immunodeficiencies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Donald B Kohn Research Topics

Disease

35Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2022 - 10/2003
17Sickle Cell Anemia (Hemoglobin S Disease)
06/2022 - 07/2013
17Neoplasms (Cancer)
11/2021 - 01/2002
15Severe combined immunodeficiency due to adenosine deaminase deficiency
01/2022 - 01/2003
14Primary Immunodeficiency Diseases
01/2021 - 12/2008
8Infections
01/2022 - 01/2002
7Graft vs Host Disease (Graft-Versus-Host Disease)
11/2021 - 01/2003
7Leukemia
10/2014 - 01/2002
6Inborn Genetic Diseases (Disease, Hereditary)
01/2021 - 11/2015
6Melanoma (Melanoma, Malignant)
01/2020 - 07/2008
5X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency)
01/2021 - 05/2010
4Chronic Granulomatous Disease
01/2022 - 05/2010
3Sarcoma (Soft Tissue Sarcoma)
10/2021 - 12/2002
3Wiskott-Aldrich Syndrome
01/2021 - 01/2016
3Lymphopenia (Lymphocytopenia)
10/2017 - 09/2011
3Prostatic Neoplasms (Prostate Cancer)
12/2013 - 07/2006
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2005 - 01/2002
2Anemia
06/2022 - 12/2018
2COVID-19
12/2021 - 01/2021
2Hemoglobinopathies
10/2020 - 01/2015
2Pain (Aches)
12/2019 - 10/2016
2Reticular dysgenesis
12/2017 - 04/2014
2Vesicular Stomatitis
10/2014 - 10/2004
2Philadelphia Chromosome
10/2005 - 01/2002
2Mucopolysaccharidosis I (Hurler Syndrome)
05/2005 - 08/2003
1Cytopenia
01/2022
1Reinfection
12/2021
1Blast Injuries
11/2021
1Open Fractures (Compound Fracture)
11/2021
1Pseudarthrosis (Pseudoarthrosis)
11/2021
1Bruton type agammaglobulinemia
01/2021
1Diarrhea
11/2020
1Hypertension (High Blood Pressure)
11/2020
1Pre-Eclampsia (Preeclampsia)
11/2020
1Body Weight (Weight, Body)
10/2020
1Esophageal Squamous Cell Carcinoma
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation
01/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2019
1Ischemia
12/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2018
1Hemophilia A (Haemophilia)
12/2018
1Immune System Diseases (Immune Disorders)
12/2018

Drug/Important Bio-Agent (IBA)

22Adenosine DeaminaseIBA
01/2022 - 10/2003
13GlobinsIBA
06/2022 - 07/2013
8T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2016 - 12/2011
5Hemoglobins (Hemoglobin)IBA
06/2022 - 01/2016
5VaccinesIBA
12/2021 - 07/2013
5AntigensIBA
09/2014 - 07/2006
4AntibodiesIBA
01/2022 - 01/2020
4Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2013
4Chimeric Antigen ReceptorsIBA
11/2021 - 10/2013
4Busulfan (Busulfex)FDA Link
10/2021 - 02/2004
3Pharmaceutical PreparationsIBA
10/2020 - 01/2007
3Complementary DNA (cDNA)IBA
10/2014 - 12/2002
2Biological ProductsIBA
12/2021 - 01/2007
2HLA Antigens (Human Leukocyte Antigens)IBA
11/2021 - 05/2017
2Immunoglobulins (Immunoglobulin)IBA
01/2021 - 08/2014
2CD40 Ligand (CD40L)IBA
01/2018 - 01/2002
2EnzymesIBA
10/2017 - 04/2014
2Adenosine (Adenocard)FDA LinkGeneric
12/2015 - 11/2005
2Alemtuzumab (Campath)FDA Link
11/2015 - 05/2007
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015 - 02/2004
2Codon (Codons)IBA
04/2015 - 03/2014
2Glycoproteins (Glycoprotein)IBA
10/2014 - 10/2004
2Anti-Bacterial Agents (Antibiotics)IBA
08/2014 - 09/2011
2Peptides (Polypeptides)IBA
05/2014 - 05/2013
2HLA-A*02:01 antigenIBA
05/2013 - 12/2011
2enhanced green fluorescent proteinIBA
02/2013 - 07/2003
2Immunologic Factors (Immunomodulators)IBA
10/2005 - 01/2002
2GlycosaminoglycansIBA
05/2005 - 08/2003
2Iduronidase (alpha-L-Iduronidase)IBA
05/2005 - 08/2003
1Amino AcidsFDA Link
06/2022
1Neutralizing AntibodiesIBA
12/2021
1Antiviral Agents (Antivirals)IBA
12/2021
1Phosphotransferases (Kinase)IBA
01/2021
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
11/2020
1ElectrolytesIBA
11/2020
1SolutionsIBA
10/2020
1InterferonsIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2020
1Cancer VaccinesIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
12/2019
1Transcription Factors (Transcription Factor)IBA
01/2019
1EndonucleasesIBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2018

Therapy/Procedure

19Therapeutics
01/2022 - 02/2004
18Hematopoietic Stem Cell Transplantation
10/2021 - 01/2002
12Transplantation
10/2017 - 01/2002
10Immunotherapy
11/2021 - 07/2006
7Cell Transplantation
01/2022 - 12/2008
7Enzyme Replacement Therapy
10/2021 - 11/2005
6Drug Therapy (Chemotherapy)
12/2017 - 10/2005
3Autologous Transplantation
10/2017 - 11/2012
2Homologous Transplantation
05/2015 - 07/2013
1Arthroplasty
11/2021
1Antibiotic Prophylaxis
01/2020
1Stem Cell Transplantation
06/2019